Cartesian Therapeutics, Inc. RNAC

US Biotechnology

$6.86 ▼ -2.28% ($-0.16)

⬇️ Below Yest. Low

Open $6.93

Prev Close $7.02

Day Range $6.84 – $7.29

52W Range $5.60 – $11.00

Market Cap $214.13M

Beta 0.71

EPS (TTM) $-5.87

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2016-06-22
Shares Out.	30,260,000
Website	cartesiantherapeutics.com/ ↗
Phone	13013488698
Employees	75
Revenue	$0
Gross Profit	$0
Net Income	-$11.5M
Free Cash Flow	-$89.9M
Total Assets	$294.3M
Total Liabilities	$424.8M
Equity	-$130.5M

About Cartesian Therapeutics, Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Cartesian Therapeutics, Inc. is a publicly traded company under the ticker symbol RNAC on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.